Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis

Tissue Antigens

Volumn 54, Issue 2, 1999, Pages 191-193

  Takashige, N ^a   Naruse, T K ^a   Matsumori, A ^b   Hara, M ^b   Nagai, S ^b   Morimoto, S ^c   Hiramitsu, S ^c   Sasayama, S ^b   Inoko, H ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac sarcoidosis; HLA; PCR RFLP; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC POLYMORPHISM; GRANULOMA; HEART DISEASE; HUMAN; IMMUNOGENETICS; JAPAN; PRIORITY JOURNAL; SARCOIDOSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHIES; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; JAPAN; LYMPHOTOXIN-ALPHA; POLYMORPHISM, GENETIC; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032861734     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540211.x     Document Type: Article

References (16)

1. Kimani A, Aguayo S, Sarcoidosis: an overview for the primary care physician. Compr Ther 1998: 24: 20-5.
2. Odum N, Iman M, Jakobsen B. HLA class II (DR, DQ, DP) in patients with sarcoidosis: Evidence of an increased frequency of DRw6. Exp Clinica Immunog 1991: 8: 227-321.
3. Ishihara M, Ohno S, Ishida T et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 1994: 43: 238-41.
4. Tiwari J, Terasaki PI. HLA and disease associations. New York: Springer Verlag, 1985: 18-27.
5. Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis. Tissue Antigens 1983: 22: 200-3.
6. Nowack D, Goebel K. Genetic aspects of sarcoidosis. Arch Intern Med 1987: 147: 481-3.
7. Seitzer U, Swider C, Stuber F et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 1997: 9: 787-9.
8. Higuchi T, Seki N, Kamizono S et al.Polymorphism of the 5́-flaking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998: 51: 605-12.
9. Zheng L, Teschler H, Guzman J, Hubner K, Striz I, Costabel U. Alveolar macrophage TNFA release and BAL cell phenotypes in sarcoidosis. Am J Respir Crit Care Med 1995: 152: 1061-6.
10. Makhatadze N. Tumor necrosis factor locus: Genetic organization and biological implications. Hum Immunol 1998: 59: 571-9.
11. Pujol-Borrell R, Todd I, Dosh M et al. HLA class II induction in human islet cells by interferon-γ plus tumor necrosis factor or lymphotoxin. Nature 1987: 326: 304-6.
12. Jacob C, Aiso S, Michie S, McDevitt H, Acha-Orbea H, Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc Natl Acad Sci U S A 1990: 87: 968-72.
13. Mizuki N, Ohno S, Sato T et al. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Bechet's disease. Hum Immunol 1995: 43: 129-35.
14. D'Alfonso S, Richiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994: 39: 150-4.
15. Wilson A, diGiovine F, Blakemore A, Duff G. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Nco I restriction of PCR product. Hum Mol Gen 1992: 1: 353.
16. Bouma G, Crusius J, Pool M et al. Secretion of tumour necrosis factor α and 1 lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996: 43: 456-63.